Abstract
Cholesterol derived from the host milieu forms a critical factor for mycobacterial pathogenesis. However, the molecular circuitry co-opted by Mycobacterium tuberculosis (Mtb) to accumulate cholesterol in host cells remains obscure. Here, we report that a functional amalgamation of WNT-responsive histone modifiers G9a (H3K9 methyltransferase) and Sirt6 (H3K9 deacetylase) orchestrate cholesterol build-up in in-vitro and in-vivo models of Mtb infection. Mechanistically, G9a, along with SREBP2, drives the expression of cholesterol biosynthesis and uptake genes; while Sirt6 represses the genes involved in cholesterol efflux. The accumulated cholesterol promotes the expression of antioxidant genes leading to reduced oxidative stress, thereby supporting Mtb survival. In corroboration, loss-of-function of G9a in vitro and in vivo by pharmacological inhibition; or utilization of BMDMs derived from Sirt6 KO mice or in vivo infection in Sirt6 heterozygous mice; hampers host cholesterol accumulation and restricts Mtb burden. These findings shed light on the novel roles of G9a and Sirt6 during Mtb infection and highlight the previously unknown contribution of host cholesterol in potentiating anti-oxidative responses for aiding Mtb survival.
Abbreviations
- HMT
- histone methyl transferase
- TB
- tuberculosis
- FM
- foamy macrophage
- ER
- endoplasmic reticulum
- HDAC
- histone deacetylase
- CFU
- colony forming unit
- BMDM
- bone marrow derived macrophage
- KO
- knock out
- LRP
- Low density lipoprotein receptor-related protein 2
- SREBP
- Sterol response element binding protein
- ABC
- ATP-binding cassette
- LDL
- low density lipoprotein
- LD
- lipid droplet
- HDL
- high density lipoprotein
- NRF2
- nuclear factor erythroid 2 (NFE2) related factor 2
- VLDL
- very low density lipoprotein
- PBMC
- polymorphic blood mononuclear cells